Clinical Trials Browser

Phase 4 × Has results × apixaban × Clear all

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism